低级别动脉瘤性蛛网膜下腔出血患者的早期治疗决策
该研究纳入2002至2013年连续146例世界神经外科联盟(WFNS)V级蛛网膜下腔出血(SAH)患者,比较预后良好与不良者的入院特征。结果显示,接受治疗的患者中36%预后良好,未治疗动脉瘤者全部死亡;仅凭入院症状难以可靠识别可能预后良好的患者。
要点
- WFNS V级SAH接受治疗的患者中36%预后良好。
- 未治疗动脉瘤的患者全部死亡。
- 入院症状对预后良好与不良的区分能力不足。
核心结论
- 超过三分之一的WFNS V级SAH接受治疗患者预后良好,未治疗动脉瘤者全部死亡,仅凭入院症状可靠识别预后良好患者似乎不可能。
研究设计与样本
- 回顾性纳入2002至2013年连续146例WFNS V级SAH患者,比较预后良好与不良者的 demographic 及疾病相关特征。
主要发现
- 146例中34例预后良好(占所有治疗患者的36%)。
- 预后良好组16例(47%)入院GCS为3分,预后不良组65例(58%)(P=0.33)。
- 预后良好组11例(33%)存在瞳孔异常,其中4例(12%)双侧瞳孔固定散大;预后不良组49例(46%)存在瞳孔异常(P<0.01)。
- 51例未治疗动脉瘤者全部死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with World Federation of Neurosurgical Societies (WFNS) grade V subarachnoid hemorrhage (SAH) mostly have a poor outcome. Correct identification of patients who might benefit from treatment remains challenging. We investigated which disease-related characteristics, present at admission, could identify patients with chance of good outcome. METHODS: In total, 146 consecutive patients with WFNS grade V SAH (2002-2013) were included. Demographic and disease-related characteristics were compared between patients with a good outcome (Glasgow Outcome Scale 4 and 5) and a poor outcome (Glasgow Outcome Scale 1-3). Subgroups were made of patients with aneurysm treatment according to outcome; 1) good outcome; 2) poor outcome, with optimal general treatment; and 3) poor outcome, general treatment discontinued. RESULTS: In total, 34 of the 146 patients had a good outcome (36% of all treated patients); 16 (47%) of these presented with a Glasgow Coma Scale score of 3, versus 65 (58%) of patients with a poor outcome (P = 0.33). Eleven (33%) patients in the good outcome group presented with pupillary abnormalities; 4 (12%) even had bilaterally fixed and dilated pupils, versus 49 (46%) in patients with a poor outcome (P < 0.01). In 51 patients, the aneurysm was not treated; all died. CONCLUSIONS: More than one third of all treated patients with WFNS grade V SAH had a good outcome. All patients in whom the aneurysm was not treated died. Reliable identification of patients who will reach good outcome, on the basis of symptoms on admission, seems impossible, as these symptoms are not discriminating enough.
引用
- Hoogmoed J, Coert BA, van den Berg R, et al. Early Treatment Decisions in Poor-Grade Patients with Subarachnoid Hemorrhage. World Neurosurg. 2018. PMID: 30077026. doi:10.1016/j.wneu.2018.07.212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。